BioNexus Gene Lab Corp. (BGLC)

USD 0.26

(-2.99%)

Operating Expenses Summary of BioNexus Gene Lab Corp.

  • BioNexus Gene Lab Corp.'s latest annual operating expenses in 2023 was 3.92 Million USD , up 153.07% from previous year.
  • BioNexus Gene Lab Corp.'s latest quarterly operating expenses in 2024 Q2 was 739.45 Thousand USD , down -95.28% from previous quarter.
  • BioNexus Gene Lab Corp. reported a annual operating expenses of 1.55 Million USD in annual operating expenses 2022, up 36.22% from previous year.
  • BioNexus Gene Lab Corp. reported a annual operating expenses of 1.13 Million USD in annual operating expenses 2021, up 155.15% from previous year.
  • BioNexus Gene Lab Corp. reported a quarterly operating expenses of 625.76 Thousand USD for 2024 Q1, up 6254.91% from previous quarter.
  • BioNexus Gene Lab Corp. reported a quarterly operating expenses of 2.88 Million USD for 2023 Q3, up 370.95% from previous quarter.

Annual Operating Expenses Chart of BioNexus Gene Lab Corp. (2023 - 2016)

Historical Annual Operating Expenses of BioNexus Gene Lab Corp. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 3.92 Million USD 153.07%
2022 1.55 Million USD 36.22%
2021 1.13 Million USD 155.15%
2020 446 Thousand USD 34.5%
2019 331.59 Thousand USD 1164.98%
2018 -31.13 Thousand USD -115.06%
2017 206.71 Thousand USD 24656.29%
2016 835.00 USD 0.0%

Peer Operating Expenses Comparison of BioNexus Gene Lab Corp.

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD 97.367%
Prenetics Global Limited 60.73 Million USD 93.541%
Star Equity Holdings, Inc. 16.27 Million USD 75.891%
CareDx, Inc 277.76 Million USD 98.588%
Exact Sciences Corporation 2.06 Billion USD 99.81%
Exagen Inc. 52.29 Million USD 92.498%
Inotiv, Inc. 246.9 Million USD 98.411%
Guardant Health, Inc. 901.62 Million USD 99.565%
Biodesix, Inc. 77.41 Million USD 94.933%
Precipio, Inc. 13.63 Million USD 71.234%
iSpecimen Inc. 16.27 Million USD 75.898%
Natera, Inc. 938.98 Million USD 99.582%
Aspira Women's Health Inc. 24.11 Million USD 83.731%
Standard BioTools Inc. 113.48 Million USD 96.543%
23andMe Holding Co. 420.73 Million USD 99.068%
Castle Biosciences, Inc. 242.78 Million USD 98.384%
Personalis, Inc. 128.14 Million USD 96.939%
Aclaris Therapeutics, Inc. 110.52 Million USD 96.45%
Applied DNA Sciences, Inc. 16.48 Million USD 76.205%
OpGen, Inc. 30.65 Million USD 87.204%
T2 Biosystems, Inc. 41.49 Million USD 90.545%
Myriad Genetics, Inc. 600.1 Million USD 99.346%
ICON Public Limited Company 755.64 Million USD 99.481%
NeoGenomics, Inc. 341.25 Million USD 98.85%
Star Equity Holdings, Inc. 16.27 Million USD 75.891%
IDEXX Laboratories, Inc. 1.09 Billion USD 99.641%
RadNet, Inc. 268.87 Million USD 98.541%
MDxHealth SA 71.25 Million USD 94.494%
Psychemedics Corporation 11.33 Million USD 65.387%
Illumina, Inc. 3.81 Billion USD 99.897%
Check-Cap Ltd. 19.28 Million USD 79.659%
Twist Bioscience Corporation 354.18 Million USD 98.892%
DarioHealth Corp. 62.17 Million USD 93.69%
Fulgent Genetics, Inc. 171.9 Million USD 97.718%
Sera Prognostics, Inc. 39.91 Million USD 90.172%
ENDRA Life Sciences Inc. 10.52 Million USD 62.711%
OPKO Health, Inc. 574.68 Million USD 99.317%
Medpace Holdings, Inc. 187.68 Million USD 97.91%
Neogen Corporation 405.23 Million USD 99.032%
Intelligent Bio Solutions Inc. 11.7 Million USD 66.495%
Prenetics Global Limited 60.73 Million USD 93.541%
Mainz Biomed B.V. 27.15 Million USD 85.553%
bioAffinity Technologies, Inc. 8.76 Million USD 55.241%
Trinity Biotech plc 46.49 Million USD 91.562%
Neuronetics, Inc. 82.25 Million USD 95.231%
Sotera Health Company 300.46 Million USD 98.694%
bioAffinity Technologies, Inc. 8.76 Million USD 55.241%